Status:
COMPLETED
Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Xenex Disinfection Services LLC
Conditions:
Healthcare Associated Infection
Clostridium Difficile Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective is to conduct a prospective, sham controlled, double-blinded, interventional crossover trial to compare standard terminal cleaning plus PX-UV (intervention) with standard terminal cleani...
Detailed Description
In 2011, 721,800 healthcare-associated infections (HAIs) were reported in the United States. The hospital environment has been increasingly recognized as an important determinant of HAI acquisition an...
Eligibility Criteria
Inclusion
- All patients admitted to the study units will be eligible
- Only patients who remain in the hospital for four calendar days or longer will be eligible for evaluation of eiHAI outcomes (the day of admission counts as calendar day one).
- Patients who do not develop an eiHAI at the time of unit discharge will be eligible for eiHAI outcomes for up to calendar 3 days following unit discharge.
Exclusion
- \- All patients not cared for on study units
Key Trial Info
Start Date :
July 7 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2020
Estimated Enrollment :
25732 Patients enrolled
Trial Details
Trial ID
NCT03349268
Start Date
July 7 2017
End Date
April 15 2020
Last Update
March 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Detroit Medical Center
Detroit, Michigan, United States, 48205